Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Harms From Uninformative Clinical Trials.

Zarin DA, Goodman SN, Kimmelman J.

JAMA. 2019 Jul 25. doi: 10.1001/jama.2019.9892. [Epub ahead of print] No abstract available.

PMID:
31343666
2.

Random-Effects Assumption in Meta-analyses-Reply.

Goodman SN, Serghiou S.

JAMA. 2019 Jul 2;322(1):82. doi: 10.1001/jama.2019.5447. No abstract available.

PMID:
31265095
3.

Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey.

Tatsioni A, Karassa FB, Goodman SN, Zarin DA, Fanelli D, Ioannidis JPA.

Ann Intern Med. 2019 May 7. doi: 10.7326/M19-0440. [Epub ahead of print] No abstract available.

PMID:
31060046
4.

Urodynamic factors associated with the large capacity bladder and incomplete emptying after prolapse repair (2009-2015).

Dobberfuhl AD, Shaffer RK, Goodman SN, Chen BH.

Neurourol Urodyn. 2019 Jun;38(5):1322-1331. doi: 10.1002/nau.23982. Epub 2019 Mar 25.

PMID:
30912192
5.

Lack of Diagnostic Utility of "Amino Acid Dysregulation Metabotypes".

Sainani KL, Goodman SN.

Biol Psychiatry. 2019 Apr 1;85(7):e41-e42. doi: 10.1016/j.biopsych.2018.11.012. Epub 2018 Dec 27. No abstract available.

PMID:
30595232
6.

Random-Effects Meta-analysis: Summarizing Evidence With Caveats.

Serghiou S, Goodman SN.

JAMA. 2019 Jan 22;321(3):301-302. doi: 10.1001/jama.2018.19684. No abstract available.

PMID:
30566189
7.

Machine Learning, Health Disparities, and Causal Reasoning.

Goodman SN, Goel S, Cullen MR.

Ann Intern Med. 2018 Dec 18;169(12):883-884. doi: 10.7326/M18-3297. Epub 2018 Dec 4. No abstract available.

PMID:
30508423
8.

How sure are you of your result? Put a number on it.

Goodman SN.

Nature. 2018 Dec;564(7734):7. doi: 10.1038/d41586-018-07589-2. No abstract available.

PMID:
30514950
9.

Inappropriate Statistical Analysis and Reporting in Medical Research: Perverse Incentives and Institutional Solutions.

Localio AR, Stack CB, Meibohm AR, Ross EA, Guallar E, Wong JB, Cornell JE, Griswold ME, Goodman SN.

Ann Intern Med. 2018 Oct 16;169(8):577-578. doi: 10.7326/M18-2516. Epub 2018 Oct 9. No abstract available.

PMID:
30304363
10.

How and why studies disagree about the effects of education on health: A systematic review and meta-analysis of studies of compulsory schooling laws.

Hamad R, Elser H, Tran DC, Rehkopf DH, Goodman SN.

Soc Sci Med. 2018 Sep;212:168-178. doi: 10.1016/j.socscimed.2018.07.016. Epub 2018 Jul 20.

11.

Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing.

Mello MM, Lieou V, Goodman SN.

N Engl J Med. 2018 Jun 7;378(23):2202-2211. doi: 10.1056/NEJMsa1713258.

12.

Assessing scientists for hiring, promotion, and tenure.

Moher D, Naudet F, Cristea IA, Miedema F, Ioannidis JPA, Goodman SN.

PLoS Biol. 2018 Mar 29;16(3):e2004089. doi: 10.1371/journal.pbio.2004089. eCollection 2018 Mar.

13.

Statistical Code to Support the Scientific Story.

Localio AR, Goodman SN, Meibohm A, Cornell JE, Stack CB, Ross EA, Mulrow CD.

Ann Intern Med. 2018 Jun 5;168(11):828-829. doi: 10.7326/M17-3431. Epub 2018 Feb 6. No abstract available.

PMID:
29404564
14.

A quality-control test for predatory journals.

Goodman SN.

Nature. 2018 Jan 11;553(7687):155. doi: 10.1038/d41586-018-00403-z. No abstract available.

PMID:
29323316
15.

Five ways to fix statistics.

Leek J, McShane BB, Gelman A, Colquhoun D, Nuijten MB, Goodman SN.

Nature. 2017 Nov 30;551(7682):557-559. doi: 10.1038/d41586-017-07522-z. No abstract available.

PMID:
29189798
16.

Sharing Clinical Research Data-Finding the Right Balance.

Lo B, Goodman SN.

JAMA Intern Med. 2017 Sep 1;177(9):1241-1242. doi: 10.1001/jamainternmed.2017.1926. Review. No abstract available. Erratum in: JAMA Intern Med. 2017 Sep 1;177(9):1399-1400.

PMID:
28715538
17.

Posing Causal Questions When Analyzing Observational Data-Reply.

Goodman SN, Schneeweiss S.

JAMA. 2017 Jul 11;318(2):201-202. doi: 10.1001/jama.2017.6235. No abstract available.

PMID:
28697249
18.

Using Design Thinking to Differentiate Useful From Misleading Evidence in Observational Research.

Goodman SN, Schneeweiss S, Baiocchi M.

JAMA. 2017 Feb 21;317(7):705-707. doi: 10.1001/jama.2016.19970. No abstract available.

PMID:
28241335
19.

Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.

Wang H, Rosner GL, Goodman SN.

Clin Trials. 2016 Dec;13(6):621-631. Epub 2016 Jun 7.

20.

STATISTICS. Aligning statistical and scientific reasoning.

Goodman SN.

Science. 2016 Jun 3;352(6290):1180-1. doi: 10.1126/science.aaf5406. No abstract available.

PMID:
27257246
21.

What does research reproducibility mean?

Goodman SN, Fanelli D, Ioannidis JP.

Sci Transl Med. 2016 Jun 1;8(341):341ps12. doi: 10.1126/scitranslmed.aaf5027. Review.

PMID:
27252173
22.

Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.

Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG.

Eur J Epidemiol. 2016 Apr;31(4):337-50. doi: 10.1007/s10654-016-0149-3. Epub 2016 May 21.

23.

Academic criteria for appointment, promotion and rewards in medical research: where's the evidence?

Moher D, Goodman SN, Ioannidis JP.

Eur J Clin Invest. 2016 May;46(5):383-5. doi: 10.1111/eci.12612. Epub 2016 Mar 22. No abstract available.

PMID:
26924551
24.

Informatics: Make sense of health data.

Elliott JH, Grimshaw J, Altman R, Bero L, Goodman SN, Henry D, Macleod M, Tovey D, Tugwell P, White H, Sim I.

Nature. 2015 Nov 5;527(7576):31-2. doi: 10.1038/527031a. No abstract available.

PMID:
26536942
25.

Meta-research: Evaluation and Improvement of Research Methods and Practices.

Ioannidis JP, Fanelli D, Dunne DD, Goodman SN.

PLoS Biol. 2015 Oct 2;13(10):e1002264. doi: 10.1371/journal.pbio.1002264. eCollection 2015 Oct.

26.

An interview with David Sackett, 2014-2015.

Sackett D, Haynes RB, Goodman SN.

Clin Trials. 2015 Oct;12(5):540-51. doi: 10.1177/1740774515597895. No abstract available.

PMID:
26428470
27.

Clinical trial data sharing: what do we do now?

Goodman SN.

Ann Intern Med. 2015 Feb 17;162(4):308-9. doi: 10.7326/M15-0021. No abstract available.

PMID:
25621467
28.

Random-effects meta-analysis of inconsistent effects: a time for change.

Cornell JE, Mulrow CD, Localio R, Stack CB, Meibohm AR, Guallar E, Goodman SN.

Ann Intern Med. 2014 Feb 18;160(4):267-70.

PMID:
24727843
29.

Opening the FDA black box.

Goodman SN, Redberg RF.

JAMA. 2014 Jan 22-29;311(4):361-3. doi: 10.1001/jama.2013.283946. No abstract available.

PMID:
24449313
30.

Raw data from clinical trials: within reach?

Doshi P, Goodman SN, Ioannidis JP.

Trends Pharmacol Sci. 2013 Dec;34(12):645-7. doi: 10.1016/j.tips.2013.10.006.

PMID:
24295825
31.

A decade of Clinical Trials.

Goodman SN.

Clin Trials. 2013;10(6):837-9. doi: 10.1177/1740774513511178. No abstract available.

PMID:
24287131
32.

Discussion: An estimate of the science-wise false discovery rate and application to the top medical literature.

Goodman SN.

Biostatistics. 2014 Jan;15(1):23-7; discussion 39-45. doi: 10.1093/biostatistics/kxt035. Epub 2013 Sep 25. No abstract available.

PMID:
24068250
33.

Mechanistic Evidence in Evidence-Based Medicine: A Conceptual Framework [Internet].

Goodman SN, Gerson J.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun.

34.

Handling of rescue and missing data affects synthesis and interpretation of evidence: the sodium-glucose cotransporter 2 inhibitor example.

Stack CB, Localio AR, Griswold ME, Goodman SN, Mulrow CD.

Ann Intern Med. 2013 Aug 20;159(4):285-8. doi: 10.7326/0003-4819-159-4-201308200-00009.

PMID:
24026261
35.

The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.

Chang X, Izumchenko E, Solis LM, Kim MS, Chatterjee A, Ling S, Monitto CL, Harari PM, Hidalgo M, Goodman SN, Wistuba II, Bedi A, Sidransky D.

PLoS One. 2013 Jul 31;8(7):e68966. doi: 10.1371/journal.pone.0068966. Print 2013.

36.

Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.

Laine C, Guallar E, Mulrow C, Taichman DB, Cornell JE, Cotton D, Griswold ME, Localio AR, Meibohm AR, Stack CB, Williams SV, Goodman SN.

Ann Intern Med. 2013 Jun 18;158(12):916-8. doi: 10.7326/0003-4819-158-12-201306180-00012. No abstract available.

PMID:
23778911
37.

Advances in regulatory science at the Food and Drug Administration.

Psaty BM, Goodman SN, Breckenridge A.

JAMA. 2013 May 22;309(20):2103-4. doi: 10.1001/jama.2013.4503. No abstract available.

PMID:
23695478
38.

Bayesian methods for evidence evaluation: are we there yet?

Goodman SN.

Circulation. 2013 Jun 18;127(24):2367-9. doi: 10.1161/CIRCULATIONAHA.113.003193. Epub 2013 May 14. No abstract available.

PMID:
23674396
39.

The research-treatment distinction: a problematic approach for determining which activities should have ethical oversight.

Kass NE, Faden RR, Goodman SN, Pronovost P, Tunis S, Beauchamp TL.

Hastings Cent Rep. 2013 Jan-Feb;Spec No:S4-S15. doi: 10.1002/hast.133. No abstract available.

PMID:
23315895
40.

An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics.

Faden RR, Kass NE, Goodman SN, Pronovost P, Tunis S, Beauchamp TL.

Hastings Cent Rep. 2013 Jan-Feb;Spec No:S16-27. doi: 10.1002/hast.134. No abstract available.

PMID:
23315888
41.

Causal inference in public health.

Glass TA, Goodman SN, HernĂ¡n MA, Samet JM.

Annu Rev Public Health. 2013;34:61-75. doi: 10.1146/annurev-publhealth-031811-124606. Epub 2013 Jan 7. Review.

42.

Ethical considerations in studying drug safety--the Institute of Medicine report.

Mello MM, Goodman SN, Faden RR.

N Engl J Med. 2012 Sep 6;367(10):959-64. doi: 10.1056/NEJMhle1207160. Epub 2012 Aug 22. No abstract available.

43.

Synthesis of fused dihydropyrano(furano)pyridines via [4 + 2]-cycloaddition of 5-alkenoxy substituted oxazoles.

Goodman SN, Mans DM, Sisko J, Yin H.

Org Lett. 2012 Mar 16;14(6):1604-7. doi: 10.1021/ol300351v. Epub 2012 Mar 7.

PMID:
22397735
44.

Quasi-random reflections on randomized controlled trials and comparative effectiveness research.

Goodman SN.

Clin Trials. 2012 Feb;9(1):22-6. doi: 10.1177/1740774511433285.

PMID:
22334465
45.

The methods of comparative effectiveness research.

Sox HC, Goodman SN.

Annu Rev Public Health. 2012 Apr;33:425-45. doi: 10.1146/annurev-publhealth-031811-124610. Epub 2012 Jan 3. Review.

PMID:
22224891
46.

An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.

Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, Califano JA, Goodman SN, Westra WH, Hoque MO, Sidransky D.

Clin Cancer Res. 2011 Jul 1;17(13):4494-503. doi: 10.1158/1078-0432.CCR-10-3436. Epub 2011 May 24.

47.

Landmark clinical trials: a new journal series.

Goodman SN.

Clin Trials. 2011 Apr;8(2):128. doi: 10.1177/1740774511402750. No abstract available.

PMID:
21478326
48.

Harry Marks: an appreciation.

Goodman SN, Rosner D, Reverby SM, Chalmers I, Rosenberg CE.

Clin Trials. 2011 Apr;8(2):123-7. doi: 10.1177/1740774511400454. No abstract available.

PMID:
21478325
49.

Pharmacogenetic testing for warfarin dosing still awaits validation.

Lefevre F, Goodman SN, Piper MA.

J Am Coll Cardiol. 2011 Feb 8;57(6):756; author reply 756-7. doi: 10.1016/j.jacc.2010.07.057. No abstract available.

50.

A systematic examination of the citation of prior research in reports of randomized, controlled trials.

Robinson KA, Goodman SN.

Ann Intern Med. 2011 Jan 4;154(1):50-5. doi: 10.7326/0003-4819-154-1-201101040-00007.

PMID:
21200038

Supplemental Content

Loading ...
Support Center